Abstract
The cloning of the opioid-receptor-like 1 (ORL1) receptor and the identification of nociceptin as its endogenous agonist have revealed a new G-protein-coupled receptor signalling system. The structural and functional homology of ORL1 to the opioid receptor systems has posed a number of challenges in understanding the often competing physiological responses elicited by these G-protein-coupled receptors. Thus, this review will attempt to summarize recent research by many groups that has revealed numerous subtleties of the ORL1 receptor and its signalling pathways, as well as document the efforts to produce high-affinity selective ligands for the ORL1 receptor that may be of value as research and therapeutic tools.
| Original language | English |
|---|---|
| Pages (from-to) | 197-212 |
| Number of pages | 16 |
| Journal | NeuroSignals |
| Volume | 11 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2002 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- G proteins
- Nociceptin
- ORL
- Pharmacology, ORL receptor
- Receptor structure
- Signalling pathways
Fingerprint
Dive into the research topics of 'The ORL1 receptor: Molecular pharmacology and signalling mechanisms'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver